throbber
PATHOLOGIC
`BASIS of
`Third Edition DISEASE
`
`STANLEY L. ROBBINS, M.D.
`Visitlnq Professor of Pathology, Harvard Medical School;
`Ser:t::t PQthoiogist, Brigham ond Women's Hospital, Boston
`
`F. B. Ma!lor11 Professor of Potr;ology, Harva,cl ,;_.;.,
`. '·,oc:-!;
`Chairman, Department of Pathology, Brighcni :}:<.: ·. •'<nien's Hospital, Boston
`
`VINAY KUMAR, M.D.
`Charles T. Ashworth Professor of Pathology, University of Texas Health Science Center
`southwestern Medical School, Dallas
`
`NOVARTIS EXHIBIT 2095
`Breckenridge v. Novartis, IPR 2017-01592
`Page 1 of 54
`
`

`

`w. B. Saw1ders uimpauy;
`
`ri1il~d~iphia, PA 19105
`
`Library of Congress Cataloging in Publication Data
`
`Robbins, Stanley L.
`
`Pathologic basis of disease.
`
`Includes bibliographical references and index.
`
`1. Pathology.
`III. Title.
`
`II. Kumar' Vinay.
`I Cotran Ramzi S.
`[DNLM: 1'. Pathology. QZ 4 R363p)
`
`RB111.R62 1984
`ISBN 0-7216-7597-2
`
`616.07
`
`83-20403
`
`Listed here is the latest translated edition of this book together with the language of the translation and the publisher.
`
`Portuguese (3rd edition)-Discos CBS_ Industria e Comercio,
`Rio de Janeiro, Brazil
`
`Spanish (3rd f!dition)-N ueva Editorial Interamericana S. A.,
`Mexico City, Mexico
`
`Yug~slavian (1st edition)-Serbo-Croat, Skolska Knjiga, Zagreb, Yugoslavia
`
`Italian (3rd edition)-Piccin Nuova Libraria S.p.A., Padova, Italy
`
`Pathologic Basis of Disease
`
`ISBN 0-7216-7597-2
`
`· ht
`© 1984 by W. B. s,.nd,., Comp'."Y· Copy,ight 1974 ,nd 1979 by W. B. S,und.,, Comp,ny, Copy, lght on "
`.,,y b<
`e "' of
`,di,g, ~
`th Uniform Copyng
`.
`d
`Con"'ntwn. S,mult,neou,ly pubh,hed m C,n,d,. All ,lght, re,e,,ed. Th;, book i, proteoted by copynght. No P
`11
`repmdueed, ,tored ln ' ret,;-,~ ,y,tem, o, trnn,mltted in ,ny fo,m o, by any mean,, electronic, mech,nical, pbotocopymg, '':,., Co•·
`o~erwise, without written permission from the publisher. Made in the United States of America. Press of W. B. Saun
`pany. Library of Congress catalog card number 83-20403.
`
`Last digit is the print number:
`
`9
`
`8
`
`7
`
`6
`
`5
`
`NOVARTIS EXHIBIT 2095
`Breckenridge v. Novartis, IPR 2017-01592
`Page 2 of 54
`
`

`

`DISEASES OF WHITE CELLS,
`DI EASES OF WHITE CELLS,
`LYMPH NODES, AND SPLEEN*
`LYMPH NODES, AND SPLEEN*
`
`15
`
`White Cells and Lymph Nodes
`11s and Lymph Nod s
`----------Whit
`
`NOIIMAL
`p~n4()1.0QY
`PATHOLOGY
`Leukopenla
`Neuttopenlo—agtonuloeqosls
`~unopenl ogranulocytosl
`ReoctWe (Inflammatory) Proliferations of White
`~ (lnftammotoly) Proll,.fCltlON ol Whit•
`Cells and Nodes
`c.llaandNodM
`Leukocytosls
`ltu ocytOSls
`Acute nonspecific lymphadenitis
`N;1J nonspecific lymphodenllls
`Chronic nonspecific lymphadonltls
`ChrOfllc nonspectllc lymphod nllls
`Neopldstic Proliferations of White Cells
`Ntc)plaltlc Prol"9rotlont ol Whit. Cella
`Malignant lymphomas
`Mongnonl lymphomas
`Non-Hodgkin's lymphomas (NHL)
`Non-Hodgkin's lymphomas (NHL)
`
`Hodgkin's disoaso (Hodgkin's
`HOdgldn'1 dlaeo .. (HOdgkln'a
`lymphoma)
`lymphoma)
`(oukomlas
`L uk mloa
`Unusual typos of loukomlas and
`Unu uol type of leuk mto, ond
`lymphomas
`lymphoma,
`Agnogonlc myolold motaplasla
`Agnog nlc my lotd metoploslo
`(myolold motaplasla with
`(my lold metoplollo wtth
`myoloflbrosls)
`my loflblO&II)
`Plasma cell dyscraslas and related
`Plosmo c II dyscralloa and r lot~
`disorders
`dlSO!dOII
`Multiple myeloma (plasma cell
`Mulllple myeloma (plalt\'\CI cell
`myeloma)
`my loma)
`
`Solitary myeloma (plasrnocytorna)
`Waldenstrorn" moctogloWlnemia
`Heavy-chain disease
`Monoclonal gommopathy of
`undetermined Ogniflconce
`Histtocytosos
`Generalized Nstiocqosis (Letterer-Stwe
`syndrome)
`EoslnopNlic granuomo--unifocal and
`mutttfocd
`MgJolrnmunoblastic tyrnphadenopathy
`
`•With gratitude to Drs Jose Hernandez, Southwestern Medical School, Dallas, Texas, for a critical review of this chapter.
`I •clic,11 · hoot, Dnll
`, T x , for critical r view of this chap r.
`
`NORMAL
`NORMAL
`The origin and differentiation of white cells (gran-
`Th origin and diffi r ntiation of whit c l\s (gran(cid:173)
`ulocytes, monocytes, and lymphocytes) were briefly
`ulocyt
`, monoc te , and lympho yt ) w r bri By
`discussed in Chapter 14 along with the other formed
`discus d in Chapter 14 along with the other formed
`elements of blood. Lymphocytes and monocytes not
`elem nts of blood. Lymphocyt
`and monocyt s not
`only circulate in the blood and lymph, but also accu-
`only circulate in the blood and lymph, but al o accu(cid:173)
`mulate in discrete and organized masses, the so-called
`mulat
`in di cret and organiz d mas es, th so-called
`lymphoreticular system. Components of this system
`lymphor ticular syst m. Components of this system
`include lymph nodes, thymus, spleen, tonsils, adenoids,
`includ lymph node , thymus, spl en, tonsils, adenoids,
`and Peyer's patches. Less discrete collections of lym-
`and P yer's patches. Less discr t coll ctions of lym(cid:173)
`phoid cells also occur in the bone marrow, lungs, and
`phoid cells also occur in the bon marrow, lungs, and
`gastrointestinal tract and other tissues. Lymph nodes
`gnstroint
`tinal tract and other ti su s. Lymph nodes
`are the most widely distributed and easily accessible
`are the mo t wid ly di tributed and easily accessible
`component of the lymphoid tissue and are therefore
`compon nt of the lymphoid tissue and are therefore
`frequently examined for the diagnosis of lymphoreticular
`frequ ntly examin d for the diagnosis oflymphoretic~lar
`disorders. It would therefore be advantageous to review
`di ord r . It would th refor b advantageous to reV1ew
`the normal morphology of lymph nodes.
`the normal morphology of lymph nod s.
`Lymph nodes, in general, are discrete structures,
`Lymph nod
`, in g neral, nre discrete structures,
`Ovoid in shape, that vary from a few millimeters to 1 to
`ovoid in hape, that vary from a fi w millimeters t~ l to
`2 cm in length. Their consistency is soft and their cut
`2 cm in l ngth. Th ir consist ncy is soft and their cut
`surface is gray-white. They are surrounded by a capsule
`surface i gray-whit . Th y ar urrounded by ~ cap ~le
`composed of connective tissue and a few elastic fibrils,
`compos cl of conn , tiv
`ti su and a fi w ela tic fibnl ,
`Pelforated at various points by afferent lymphatics that
`perforat d at variou points by affi r nt lymphatics that
`empty into the peripheral sinus subjacent to the capsule.
`mpty into th p riph rul sinu subjacent to th capsule.
`Branches of the sinus extend into the nodes and termi-
`Branche of th
`inu
`t nd into th nod s and t rmi(cid:173)
`nate at the hilus, where the efferent lymphatics emerge.
`nat at the hilu wh r, th
`ffi r nt lymphatics m rge.
`All lymphatics are lined with reticuloendothelial cells.
`All lymphatic ;re Jin d with r ticulo ndoth lial cell .
`Situated in the cortex or peripheral portion of the node
`ituat d in th cort x or p riph ral portion of th nod
`are spherical aggregates of lymphoid tissue, the so-
`are ph rical aggr gat s of lymphoid tis u , the ·o(cid:173)
`called primary follicles, which represent the B-cell
`call <l primary follicl s, which r prese~t th B~cell
`areas. Upon antigenic stimulation, the primary follicles
`ar as. Upon nntig ni
`timulation, th pnmary folhcl
`enlarge and develop pale-staining germinal centers com-
`nlarg and d v ·lop pal _ taining g ~rminul c 1~t r co_m(cid:173)
`Posed of follicular center cells (lymphocytes in varying
`po cd of follicular c nt r
`ll (lymphocyt · m v~~ng
`stages of activation, described on p, 663). Surrounding
`st ge of activation d s rib d on p. 663). urroun mg
`these germinal centers are mantles of small unchal-
`th
`g rminul
`~t rs ar mantl 'S of smnll unchal-
`
`lenged B cells. The T cells occupy the parafollicular
`I nged B cells. The T cells occupy the paraf~llicular
`regions (p. 158). The medullary cords, occupying the
`regions (p. 158). The medullary cord , occupymg the
`central portion of the node, contain predominantly
`central portion of the node, contain predominantly
`plasma cells and some lymphocytes. A delicate reticulin
`plasma cells and some lymphocytes. A delicate reticulin
`that connects peripherally with the capsule is the pre-
`that connects peripherally with the capsule is the pre(cid:173)
`dominant supporting structure within the lymph nodes.
`dominant supporting structure within the lymph nodes.
`The morphologic description of the lymph node
`The morphologic description of the lymph node
`just given is highly idealized and falsely static. The size
`just given is highly idealized and falsely static. The size
`and morphology of lymph nodes are modified by stress,
`and morphology of lymph nodes are modified by stress,
`thyroid and adrenal function, and immune responses.
`thyroid and adrenal function, and immune responses.
`As secondary lines of defense, they are constantly re-
`As secondary lines of defense, they are constantly re(cid:173)
`sponding to stimuli, even in the absence of clinical
`sponding to stimuli, even in the absence of clinical
`disease. Trivial injuries and infections effect subtle
`disease. Trivial injuries and infections effect subtle
`changes in lymph node histology. More significant bac-
`changes in lymph node histology. More significant bac(cid:173)
`terial infections inevitably produce enlargement of
`terial infections inevitably produce enlargement of
`nodes and sometimes leave residual scarring. For this
`nodes and sometimes leave residual scarring. For this
`reason, lymph nodes in the adult are almost never
`reason, lymph nodes in the adult are almost never
`normal," since they usually bear the scars of previous
`"normal," since they usually bear the scars of previous
`events, rendering the inguinal nodes particularly inap-
`events, rendering the inguinal nodes particularly inap(cid:173)
`propriate for evaluative biopsies. Except in the child, it
`propriate for evaluative biopsies. Except in the child it
`is diffcult to find a "normal" node, and in histologic
`is diffi~ult t? ~nd a "normal" node, and in histologic
`evaluations it is often necessary to distinguish changes
`evaluations 1t 1s often necessary to distinguish changes
`secondary to past experience from those related to
`secondary to past experience from those related to
`present disease.
`present disease.
`
`PATHOLOGY
`PATHOLOGY
`Disorders of white cells may be classified into two
`Disord rs of white c Us may be classified into h
`broad categories, proliferative and those characterized
`broad cat~gories, proliferative and those characteriz~
`by a deficiency of leukocytes, i.e., leukopenias. Prolif-
`by ~ deflc1enc~ of leukocytes, i.e., leukopenias. Prolif-
`erations of white cells and lymph nodes miy be reactive
`rations of wlute cells and l mph nodes
`.,_ he
`· s ·
`.
`or neoplastic. Since their major function is host defense,
`l
`mu.
`or n ?P astic. me th ir major function is h
`reactive
`t d fe
`reactive proliferation in response to an underlying pri-
`r active prolifi ration in response to an u do l _e ns~,
`mary, often microbial disease is fairly common. Neo-
`mary, often microbial disease is fairly n
`r ymg pn-
`eo-
`common.
`653
`
`NOVARTIS EXHIBIT 2095
`Breckenridge v. Novartis, IPR 2017-01592
`Page 3 of 54
`
`

`

`654 DISEASES OF WHITE CELLS, LYMPH NODES. AND SPLEEN
`654 DISEASES OF WHITE CELLS, LYMPH NODES, ANO SPLEEN
`plastic disorders, although less frequent, are much more
`important. In the following discussion, we will describe
`first the leukopenic states and summarize the common
`reactive disorders, and then consider in some detail
`malignant proliferations of the white cells that in many
`instances arise in the nodes.
`
`LEUKOPENIA
`LEUKOPENIA
`The number of circulating white cells may be
`ma h
`markedly decreased in a variety of disorders. An abnor-
`mally low white cell count (leukopenia) may occur
`because of decreased numbers of any one of the specific
`types of leukocytes, but most often involves the neutro-
`phils (neutropenia, granulocytopenia). Lymphopenias
`are much less common, and in addition to the congenital
`immunodeficiency diseases (p. 205) they are associated
`with specific clinical syndromes (e. g. , Hodgkin's disease,
`nonlymphocytic
`leukemias,
`following corticosteroid
`therapy, and occasionally in chronic diseases). Only the
`more common leukopenias involving granulocytes will
`be discussed here.
`
`Neutropenia—Agranulocytosis
`Neutropenla-Agranulocytosls
`Reduction in the number of granulocytes in the
`R duction in the numb r of granulocyte
`in th
`peripheral blood—neutropenia—may be seen in a wide
`peripheral blood-neritropenia-may be seen in a wid
`variety of circumstances. Frequently it is transient and
`variety of circumstances. Frequently it i tran i nt and
`of trivial significance. Sometimes the reduction in cir-
`of trivial significance. Sometim s the r duction in cir(cid:173)
`culating neutrophils is marked and has serious conse-
`is marked and has
`riou cons -
`culating neutrophil
`quences by predisposing to infections. When of this
`quences by predisposing to infection . When of thi
`magnitude, it is referred to as agranulocytosis. The
`magnitude, it is referred to a agranulocyto i . Th
`lymphocytes are not affected, so the percentage of
`lymphocytes are not affected, o th p re ntage of
`lymphocytes is increased (relative lymphocytosis).
`lymphocytes i increa ed (relative lymphocyto i ).
`PATHOGENESIS. Considering first the broad topic
`PATHOGENESIS. Considering fir t the broad topic
`of neutropenia, whatever its severity, a reduction in
`of neutropenia, whatever it s v rity, a reduction in
`circulating granulocytes will occur if (1) granulopoiesis
`circulating granulocytes will occur if (1) granulopoi si
`fails to keep pace with the normal tumov r rate of
`neutrophils or (2) there is accelerated removal of neu-
`neutrophils or (2) there is accelerated removal of n u(cid:173)
`trophils from the circulating blood. You recall that the
`trophils from the circulating blood. You recall that th
`neutrophil is a very short-lived cell having a half-life of
`neutrophil is a very short-lived cell having a half-life of
`only six to seven hours. Any impairment of granulo-
`only six to seven hours. Any impairment of granulo(cid:173)
`poiesis can therefore induce a neutropenia within hours
`poiesis can therefore induce a neutrop nia within hours
`to a few days.
`to a few days.
`Inadequate or ineffective granulopoiesis may be
`Inadequate or ineffective granulopoiesis may b
`encountered with (l) suppression of pluripotent myeloid
`encountered with (1) suppr ssion of pluripotent m eloid
`stem cells, as occurs in aplastic anemia (p. 638) and a
`stem cells, as occur
`in aplastic an mia (p. 63 ) and a
`variety of leukemias and lymphomas (p. 683)-—in these
`variety of leukemias and lymphoma (p. 683)-in th s
`conditions, granulocytopenia is accompanied by anemia
`conditions, granulocytop nia is accompanied by an mia
`and thrombocytopenia; (2) suppression of the committed
`and thrombocytop nia; (2) suppr ssion of th committed
`granulocytic precursors, which occurs after exposure to
`to
`granulocytic pr cursors, which occurs aft r exposur
`certain drugs, o discussed below; (3) megnloblastic
`anemias, due to vitamin 1312 or folate deficiency (p. 630),
`anemias, due to vitamin 8 12 or folat d fici ncy (p, 630),
`in which defective DNA synthesis produces abnormal
`in which cl •fectiv D A ynth sis produc s abnormal
`granulocytic precursors, rendering them susceptible to
`granulocytic pr cursors, r nd ring th m susc ptibl
`to
`intramedullary death (ineffective granulopoiesis). Mar-
`intramcdullary death (in ffi
`tiv granulopoi •is). Mar(cid:173)
`row granulopoiesis is increased but the number of
`row granulopolesis is incr a cl hut the numb r of
`mature neutrophils entering the blood is decreased.
`mature ne~1trophils ent ring the blood i deer used.
`
`Accelerated removal or destruction of neutrophdt
`(l) immunologiGilly mediated
`is encountered
`to the neutrophils, which may be idiopathic with n;
`other abnormality, associated with a well-defined im-
`munologic disorder (e.g.. Felty•s syndrome. p. 1.135),
`or produced by exposure to drugs; (2) splenic seques_
`tration in which excessive destruction o«urs
`to cnlargcmcnt of the spleen (p, 6!h)), associated also
`with excessive destruction of red o•lls and platelets.
`Among the many associations mentioned, the most
`significant neutropenias (agranulocytoscs) are produced
`by drugs.' Certain drugs, such as alkylating ak'onts am]
`antimctabolites used in cancer treatment. produce
`agranulocytosis in a predictable, dose-related
`They cause a generalized suppression of the iFjne mar.
`row, and therefore other cells are also affected Laplastic
`anemia). Agranulocytosis may also be encount€'5Ul as an
`idiosyncratic reaction to a large variety of agents.
`roster of implicated drugs includes aminopyllte, chlor-
`amphenicol, sulfonamides, chlorpromazine, thiouracd,
`and phenylbutazone. Although the mechanism of agran-
`ulocytosis here 'is obscure, both decreased production
`and increased destruction have been implicated. The
`neutropenia induced by chlorpromazine and related
`phenothiazines is of slow onset and is believed to result
`from the suppression of granulocytic precursors in the
`bone marrow. Chlorpromazine can inhibit DNA synthe-
`sis of marrow cells in vitro, and therefore it is postulated
`that certain individuals unusually sensitive to this effect
`develop agranulocytosis. Neutrophil production gradu-
`ally becomes normal after the cessation of drug therapy.
`Agranulocytosis following administration of aminopyr-
`ine, thiouracils, and certain sulfonamides is believed to
`result from immunologically mediated destruction of
`mature neutrophils. Antibodies reactive against a com-
`plex between the drug or its metabolite (acting as the
`hapten) and leukocyte proteins may evoke a Tvpe Il
`hypersensitivity reaction. Alternatively, neutrophils
`may be damaged as innocent bystanders by the adsorp-
`tion of drug-antibody complexes on the sufface and the
`subsequent activation of complement. In many cases,
`no antecedent cause of neutropenia can be detected but
`autoimmunity is suspected, since serum antibodies di-
`rected against neutrophil-specific antigens can be de-
`
`MORPHOLOGY. The anatomic alterations in the bone
`.
`MORPHOLOGY Th
`e anat?m,c alterations in the ~e
`marrow de end
`•
`When it is caused by excessive destruction of the mature
`When it is Pcaus: the underl¥ing basis of the neutropenia.
`neutrophils, the marrow may be hypercellular with increased
`by excessive destruction of the mature
`neutrophils th
`numbers of immature granulocytic precursors. HypercellU•
`numbers of i~mrr:i~rrow may be hypercellular with increased
`larity is also seen with ineffective granulopoiesis, as occurs
`larity Is also seen ure granulocytic precursors. Hypercellu(cid:173)
`in megaloblastic anemias. Agranulocytosis caused by agents
`ln megaloblastlc an~lt~ ineffective granulopoiesis, as occurs
`that affect the committed granulocytic precursors are under-
`that affect the comm~'~· Agranulocytosis caused by agents
`standably associated with hypocellular marrow, resulting
`standably associat I e granulocytic precursors are under(cid:173)
`from greatly decreased leukopoietic elements. Erythropoie-
`from greatly decreaed d~lth hypocellular marrow, result!~
`sis and megakaryocytes usually remain at normal levels, but
`sis and megaka oc se eukopofetic elements. Erythrop01e·
`with certain myelotoxic drugs all marrow elements may be
`with certain myZotf ~s dusually remain at normal levels, but
`affected. Occasionally, increased numbers of plasma cells
`affected. Occasional~ c
`rugs all marrow elements may b8
`and lymphocytes are found in the marrow, particularly as
`and lymphocyt
`Y, Increased numbers of plasma cells
`the marrow becomes acellular.
`the marrow b~;maere found in the marrow particularly as
`s acellular.
`'
`
`NOVARTIS EXHIBIT 2095
`Breckenridge v. Novartis, IPR 2017-01592
`Page 4 of 54
`
`

`

`Infections are a characteristic feature of agranulo.
`Infection• tal re a chatrl a1cterl tic f ature of agranulo(cid:173)
`cytosis. Ulcerating necrotizing lesions of the gingiva, floor
`cyto•I•· Ulcers ng necro z ng leslon of the glnglva, floor
`of the mouth, buccal mucosa, pharynx, or anywhere within
`of the mouth, buccal mucosa, pharynx, or anywh re within
`the oral cavity (agranulocytic angina) are quite characteristic
`tt,e oral cavity (agranulocytlc angina) aro quit character! tic
`of agranulocytosis (Fig. 15—1). These ulcers are typically
`typlcall
`r
`of agranulocytosls (Fig. 15-1 ). These ulc rs
`deep, undermined, and covered by gray to green-black
`de8P, undermined, and cover d by gray to gre n-blac~
`necrotic membranes from which numbers of bacteria or fungi
`necrotic membranes from which numbers of bacteria or fun 1
`can be isolated. Similar ulcerations may occur in the skin,
`can be Isolated. Slmllar ulcerations may occur In the ski~
`vagina, anus, or gastrointestinal tract, but these sites are
`vagina, anus, or gastrolntestlnal tract, but these sites ar~
`much less frequently involved. Severe necrotizing infections
`much less frequently Involved. Severe necrotlzlng Infections
`are also encountered, but less prominently, in the lungs,
`are also encountered, but less prominently, In the lungs,
`urinary tract, and kidneys. All these sites of infection are
`urinary tract, and kidneys. All these sites of infection are
`characterized by massive growth of bacteria (or other
`characterized by massive growth of bacteria (or other
`agents) with relatively poor leukocytic response. In many
`agents) with relatively poor leukocytic response. In many
`instances, the bacteria grow in colony formation (botryomy-
`instances, the bacteria grow in colony formation (botryomy(cid:173)
`cosis) as though they were cultured on nutrient media. The
`cosis) as though they were cultured on nutrient media. The
`regional lymph nodes draining these infections are enlarged
`regional lymph nodes draining these infections are enlarged
`and inflamed. The spleen and liver are rarely enlarged.
`and inflamed. The spleen and liver are rarely enlarged.
`CLINICAL COURSE. Agranulocytosis tends to follow
`to foll ow
`t nd
`tosi
`CLINICAL COURSE. granulo
`a fairly characteristic clinical pattern. The initial symp-
`initial symp(cid:173)
`a fairly charact ri tic clinical patt rn . Th
`toms are often malaise, chills, and fever, followed in
`toms are often malais , chill , and fi
`r, foll owed in
`sequence by marked weakness and fatigability, symp-
`sequence by marked weakn s and fatigabili ty, ymp(cid:173)
`toms that stem from the severe infections characteristic
`infection characte ri tic
`r
`toms that stem from the s
`of this disorder. In severe agranulocytosis with virtual
`, ith virtual
`of this disorder. In severe agranuloc to i
`absence of neutrophils, these infections may become so
`absence of neutrophil , these in.Fi ctions may become o
`overwhelming as to cause death within a few days. Less
`overwhelming as to cau e death within a few day . Le s
`extreme depression of the marrow may appear insidi-
`extreme depression of the marrow may appear insidi(cid:173)
`ously and come to light only during the investigation of
`ligation of
`ously and come to light only during the inv
`frequent and persistent minor infections.
`frequent and persistent minor infections .
`Characteristically, the total white cell count is
`the total white cell count i
`Characteristically,
`reduced to 1000 cells per mm3 of blood and, in certain
`reduced to 1000 cells per mm 3 of blood and, in certain
`instances, to levels as low as 200 to 300 cells. Usually
`instances, to levels as low as 200 to 300 cells. U ually
`there is no associated anemia, save that caused by the
`there is no associated anemia, save that caused by the
`infections, nor is there thrombocytopenia.
`infections, nor is there throm bocytope nia.
`The prognosis is very unpredictable. Before the
`The prognosis is very unpredictable. B fore th
`advent of antibiotics, the mortality rate ranged between
`advent of antibiotics, the mortality rate ranged betw~en
`70 and 90%. At present the antibiotics and supportive
`70 and 90%. At present the antibiotics and supportive
`measures such as neutrophil transfusions allow better
`fu ·ons aJlow bette r
`h .1
`Hi
`f
`trans si
`survival since, in many instances, the adverse effects of
`measures such as neutrop 1
`survival since, in many instances, the adverse e ects o
`
`...... /i;_;~. .
`? ,·, . •.
`;,✓--· • a .~ ..
`..
`... .,,
`.. ,~· .'1,.
`-
`•· -
`·•t:rar1;.,
`t
`
`. ...
`-
`
`•
`
`:tit '
`
`.
`
`.
`. . ...
`'
`-.•
`. J
`
`. ...
`0
`
`'.:.j ~ ili.1
`f"
`./
`"
`.
`I.
`• .
`Ji·
`• ... - ~
`•
`•xy,, .. •
`.
`·•
`t
`
`..
`• · .
`
`Figure 15-1. Granulocytopenia. Gingival margins show chronic
`Qppurative necrotizing infection due to loss of protective white cells
`
`h w chronic
`. . I margins s o
`ells
`Flgu
`i
`11 .... " 15-1 . Granulocytopenla . Gingiva of protective wh te c
`;;wurauve necrotizing infection due to loss
`Circu1a11on.
`circulation.
`
`655
`White Cells and Lymph Nodes
`655
`White Cells and Lymph Nod s
`the toxic drug are discovered early and the depression
`r >d arl and th • d •pr•
`io n
`:o
`th • toxi · drug ar • di
`of Whitc cells eventually remits. The idiopathic form,
`•vcn tu ll y r •mil . lb• idiopathic form ,
`•II
`of whit •
`too, may spontaneously remit or may progressively
`too, muy ponlan •ou ·ly r mit or may progr • siv ly
`worsen, leading to death.
`wor •n, lt•udl11g lo cJ •ttth.
`
`REACTIVE (INFLAMMATORY)
`REACTIVE (INFLAMMATORY)
`PROLIFERATIONS OF WHITE CELLS
`PROLIFERATIONS OF WHITE CELLS
`Leukocytosis
`Leukocytosls
`Leukocytosis is a common reaction in a variety of
`vari ·tv of
`L uko ytosis is a common Paction in
`inflammatory states. The particular white cell series
`;ri
`•JI
`•. Th particu lar whit,
`·t t
`inflammatory
`affected varies with the underlying cause. In Chapter 2
`affi •cted varies with th• underlying cau e . ln hapt ·r 2
`we discussed polymorphonuclear leukocytosis (granulo-
`w discus ed polymorphonuclear leukoctJlosis (granulo-
`cytosis), which accompanies acute inflammation. Pyo-
`to is), which accompanie acu te inflammation . Pyo(cid:173)
`genic infections are common causes of neutrophilic
`of n utrophilic
`gen ie infi ctions are common cau
`leukocytosis, but it may also result from nonmicrobial
`le ukocytosi , but it may al o result from nonmicrobial
`stimuli such as tissue necrosis caused by burns or
`tissue necro is caused by burn or
`timuli such as
`myocardial infarction. In patients with severe, life-
`infarction . In patie nts with evere, life(cid:173)
`myocardial
`threatening sepsis, in addition to leukocytosis there may
`threatening sepsis, in addition to le ukocytosis there may
`be morphologic changes in the neutrophils such as toxic
`be morphologic changes in the neutrophils such as toxic
`granulations, Döhle bodies, and cytoplasmic vacuoles.
`granulations, Dohle bodies, and cytoplasmic vacuoles.
`Toxic granules are coarse and darker than the normal
`Toxic granules are coarse and darker than the normaJ
`neutrophilic granules. Although their precise origin is
`neutrophilic granules. Although their precise origin is
`not entirely clear, they are believed to represent ab-
`not entirely clear, they are believed to repre ent ab(cid:173)
`normal forms of azurophilic granules. Döhle bodies are
`normal forms of azurophilic granuJes. Dohle bodies are
`pale blue, round or oval inclusions that represent ag-
`pale blue, round or oval inclusions that represent ag(cid:173)
`gregates of the rough endoplasmic reticulum.
`gregates of the rough endoplasmic reticulum .
`Eosinophilic leukocytosis is characteristic of allergic
`Eosinophilic leukocytosis is characteristic of aUergic
`disorders such as bronchial asthma, hay fever (p. 727),
`disorders such as bronchial asthma, hay fever (p. 727),
`parasitic infections, and some diseases of the skin. The
`parasitic infections, and some diseases of the skin. The
`latter include pemphigus, eczema, and dermatitis her-
`latter include pemphigus, eczema, and dermatiti her(cid:173)
`petiformis, all of which are probably immunologic in
`pe tifonnis, all of which ar probably immunologic in
`origin. Elevations in monocyte count may be seen in
`origin. Elevations in monocyte count may be seen in
`several chronic infections including tuberculosis, bac-
`several chronic infections including tuberculosis, bac(cid:173)
`terial endocarditis, brucellosis, rickettsiosis, and ma-
`terial endocarditis, brucellosis, rickettsio is, and ma(cid:173)
`laria. Certain collagen vascular diseases such as systemic
`laria. Certain collagen vascular diseases such as sy temic
`lupus erythematosus (SLE) and rheumatoid arthritis are
`lupus erythematosus (SLE) and rheumatoid arthriti are
`also associated with monocytosis. Lymphocytosis may
`also associated with monocytosis. Lymphocytosis may
`accompany monocytosis in chronic inflammatory states
`tat
`accompany monocytosis in chronic inflammatory
`such as brucellosis and tuberculosis, representing in
`such as brucellosis and tuberculo i , repre enting in
`these instances a sustained activation of the immune
`these instances a sustain d activation of th
`immune
`response. The lymphocyte count may also be increased
`response. The lymphocyte count may al o be increased
`in acute viral infections such as viral hepatitis, in cyto-
`in acute viral infections such as viral hepatitis, in c to(cid:173)
`megalovirus infections, and particularly in infectious
`megaJovirus infections, and particuJarly in infectious
`mononucleosis (p. 288).
`mononucleosis (p. 288).
`In most instances, reactive leukocytosis is easy to
`to
`to is i ea
`In most in tances, reactive I uko
`distinguish from neoplastic proliferation of the white
`di tinguish from neoplastic proliferation of th white
`cells (i.e., leukemias) by the rarity of immature cells in
`c lls (i. . , leuk mias) by the rarity of immatur c lls in
`the blood. However, in some inflammatory states, many
`inflammatory state , many
`th blood . How ver, in som
`immature white cells may appear in the blood and a
`immatur whit c II may app ar in the blood and a
`picture of leukemia may be simulated (leukemoid reac-
`pictur , of leuke mia ma b simuJat d (l ukemoid reac(cid:173)
`tion). The distinction from leukemias may then be
`tion ). Th di tinction from I uk mias may th n b
`difficult, as discussed on page 680.
`difficult, as discuss d on pag 680.
`Infections and other inflammatory stimuli may not
`Infi ctions and oth r inffammator stimuli may not
`only cause leukocytosis but also involve the lymph
`I mph
`th
`I ukocytosi but al o in ol
`on ly cau
`nodes, which act as defensive barriers. The infections
`tion
`inf(cid:141)
`nod, , which act a d fen ive barrier-. Th
`that lead to lymphadenitis (described below) are so
`o
`(d cribed b low) ar
`that ) ad to I mphnd niti
`numerous and varied that it is impossible to detail each,
`to d tai l ach,
`num rous and vari <l that It I impo sibl
`since it would be a virtual catalog of all systemic
`n virtual catalog of aJ I ystemic
`it wou ld b
`sine
`
`NOVARTIS EXHIBIT 2095
`Breckenridge v. Novartis, IPR 2017-01592
`Page 5 of 54
`
`

`

`656 DISEASES OF WHITE CELLS, LYMPH NODES, AND SPLEEN
`656 DISEASES OF WHITE CELLS, L VMPH NODES, AND SPLEEN
`microbiologic diseases. Moreover, in most instances the
`lymphadenitis is of a banal variety and is entirely
`nonspecific, designated acute or chronic nonspecific
`lymphadenitis.
`
`Acute Nonspecific Lymphadenltls
`Acute Nonspecific Lymphadenltls
`Lymph nodes undergo reactive changes whenever
`challenged by microbiologic agents or their toxic prod-
`ucts, or by cell debris and foreign matter introduced
`into wounds or into the circulation, as in drug addiction.
`Acutely inflamed nodes are most commonly caused
`by direct microbiologic drainage, and are seen most
`frequently in the cervical area in association with infec-
`tions of the teeth or tonsil, or in the axillary or inguinal
`regions secondary to infections in the extremities. Sim-
`ilarly, acute lymphadenitis is found in those nodes
`draining acute appendicitis, acute enteritis, or any other
`acute infections. Generalized acute lymphadenopathy is
`characteristic of viral infections and bacteremia, partic-
`ularly in children. The nodal reactions in the abdomen—
`mesenteric adenitis—may induce acute abdominal
`symptoms closely resembling acute appendicitis, a dif-
`ferential diagnosis that plagues the surgeon.
`Macroscopically, the nodes become swollen, gray-red,
`Macroscopically, the nodes become swollen, gray-red,
`and engorged. The capsules are generally intact, but per-
`and engorged. The capsules are generally intact, but per(cid:173)
`meation of infection may lead to inflammatory changes in
`meation of infection may lead to inflammatory changes In
`the perinodal tissues. Histologically there is prominence of
`the perinodal tissues. Histologically there is prominence of
`the lymphoid follicles and large germinal centers containing
`the lymphoid follicles and large germinal centers containing
`numerous mitotic figures. Histio

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket